Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNGENE INTERNATIONAL Gains 4%; BSE HEALTHCARE Index Up 0.3%
Thu, 24 Oct 9:47

SYNGENE INTERNATIONAL Gains 4%; BSE HEALTHCARE Index Up 0.3%Image source: peterschreiber.media/www.istockphoto.com

SYNGENE INTERNATIONAL share price has zoomed 4% and is presently trading at Rs 866.0.

Meanwhile, the BSE HEALTHCARE index is at 42,817.6 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 12.2%) and AJANTA PHARMA (up 1.4%).

DR. LAL PATHLABS (down 3.0%) and MAX HEALTHCARE INSTITUTE (down 1.2%) are among the top losers today.

Over the last one year, SYNGENE INTERNATIONAL has moved up from Rs 696.3 to Rs 866.0, registering a gain of Rs 169.8 (up 24.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,817.6, registering a gain of 55.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 213.7%), Glenmark Pharma (up 121.2%) and SUVEN PHARMACEUTICALS (up 119.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,861.8 (down 0.3%).

The top losers among the BSE Sensex today are Hindustan Unilever (down 5.4%) and Nestle (down 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,362.2 (down 0.3%). Hindustan Unilever and Hindalco are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 79,861.8, registering a gain of 15,289.9 points (up 23.7%).

SYNGENE INTERNATIONAL Financial Update...

SYNGENE INTERNATIONAL net profit fell 8.9% YoY to Rs 1,061 million for the quarter ended September 2024, compared to a profit of Rs 1,165 million a year ago. Net sales declined 2.1% to Rs 8,910 million during the period as against Rs 9,101 million in July-September 2023.

For the year ended March 2024, SYNGENE INTERNATIONAL reported 9.8% increase in net profit to Rs 5,100 million compared to net profit of Rs 4,644 million during FY23. Revenue of the company grew 9.3% to Rs 34,886 million during FY24.

The current Price to earnings ratio of SYNGENE INTERNATIONAL, based on rolling 12 month earnings, stands at 72.3.


Equitymaster requests your view! Post a comment on "SYNGENE INTERNATIONAL Gains 4%; BSE HEALTHCARE Index Up 0.3%". Click here!